Bain Capital Life Sciences Investors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $37.9M | Sell |
|
|||||
|
2023
Q2 | $41.5M | Hold |
|
|||||
|
2023
Q1 | $37M | Hold |
|
|||||
|
2022
Q4 | $42.2M | Hold |
|
|||||
|
2022
Q3 | $45.3M | Hold |
|
|||||
|
2022
Q2 | $43M | Buy |
|
|||||
|
2022
Q1 | $44.6M | Hold |
|
|||||
|
2021
Q4 | $57.7M | Buy |
|
|||||
|
2021
Q3 | $35.4M | Hold |
|
|||||
|
2021
Q2 | $31.7M | Buy |
|
|||||
|
2021
Q1 | $16.4M | Hold |
|
|||||
|
2020
Q4 | $15.1M | Hold |
|
|||||
|
2020
Q3 | $16.8M | Hold |
|
|||||
|
2020
Q2 | $18.8M | Buy |
|